Central Omega Resources Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Central Omega Resources Tbk. trades at Rp660 (market cap 3.58T, 4.46M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Central Omega Resources Tbk. is far larger — about 21.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Central Omega Resources Tbk. is more actively traded (4.46M versus 71K). Which is the better fit depends on your goals.
| DKFT | OBAT | |
|---|---|---|
Market Cap | 3.58T | 167.37B |
Volume | 4.46M | 71K |
Lot | 44.65K | 710 |
Turnover | 2.93B | 17.51M |
Average Price | 656.73 | 246.63 |
Value | 2.93B | 17.51M |
Indicative Equilibrium Price | 660 | 246 |
Indicative Equilibrium Volume | 813 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Central Omega Resources Tbk (formerly PT Duta Kirana Finance Tbk) was established based on Notarial Deed No.36 dated February 22, 1995 of Toety Juniarto, S.H., a public notary in Jakarta.
Read more on DKFT →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →